Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$89,128
+$32,426 QoQ
Shares Held
54,680
+57.2% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $43,640,056 across 72 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 58,590 | $7,776,650 | |||
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | TWST |
Twist Bioscience Corp
|
18,976 | $1,952,250 | |
| 7 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 8 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 |
All Filings in CDXS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $89,128 | 54,680 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $56,702 | 34,787 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $87,661 | 35,927 | Shares | Other | 2025-11-14 | |
| 2023-09-30 | $99,784 | 52,796 | Shares | Other | 2023-11-14 | |
| 2023-03-31 | $74,118 | 17,903 | Shares | Other | 2023-06-01 | |
| 2022-12-31 | $93,008 | 19,959 | Shares | Other | 2023-02-14 | |
| 2020-12-31 | $210,921 | 9,662 | Shares | Other | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||